Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-01

Clinical Trial Update: Does Bicarbonate in Addition to Theophylline Reduce CIN? [NA]

View source ↗

Summary

A completed clinical trial tested whether adding bicarbonate to theophylline reduces contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)
  • Theophylline (Theophylline)

Snippet

Sponsor: Technical University of Munich | Conditions: Radiographic Contrast Agent Nephropathy | NA | Status: COMPLETED